Company

Xencor Inc (XNCR)

Standardized SEC financial data for Xencor Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001326732 · NASDAQ · Pharmaceutical Preparations.

Operating margin

-141.3%

Net margin

-73.2%

Revenue growth (YoY)

13.7%

Return on equity

-14.5%

ROIC

-21.3%

Free cash flow

-$138.3M

Debt / equity

0.12×

Current ratio

6.25×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$122.7M	$275.1M	$164.6M	$174.6M	$110.5M	$125.6M
R&D expense	$169.8M	$192.5M	$199.6M	$253.6M	$227.7M	$239.4M
SG&A expense	$29.7M	$38.8M	$47.5M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$163.5M	$143.5M	$53.9M	$54.2M	$41.3M	$54.4M
Total current assets	$637.7M	$424.4M	$675.3M	$635.6M	$577.6M	$599.8M
Property, plant & equipment	$21.7M	$28.2M	$59.2M	$66.1M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$5.0M	-$16.9M	$24.5M	-$77.9M	-$202.2M	-$135.1M
Capital expenditures	$10.5M	$13.3M	$38.5M	$18.4M	$6.1M	$3.1M
Free cash flow	-$15.5M	-$30.2M	-$14.0M	-$96.4M

Get XNCR data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/XNCR/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/XNCR/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View XNCR filings on SEC EDGAR →